GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Tau Medical Ltd (NAS:DRTS) » Definitions » Enterprise Value

Alpha Tau Medical (Alpha Tau Medical) Enterprise Value : $128.66 Mil (As of May. 18, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Alpha Tau Medical Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Alpha Tau Medical's Enterprise Value is $128.66 Mil. Alpha Tau Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-29.07 Mil. Therefore, Alpha Tau Medical's EV-to-EBIT ratio for today is -4.43.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Alpha Tau Medical's Enterprise Value is $128.66 Mil. Alpha Tau Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-29.07 Mil. Therefore, Alpha Tau Medical's EV-to-EBITDA ratio for today is -4.43.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Alpha Tau Medical's Enterprise Value is $128.66 Mil. Alpha Tau Medical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil. Therefore, Alpha Tau Medical's EV-to-Revenue ratio for today is .


Alpha Tau Medical Enterprise Value Historical Data

The historical data trend for Alpha Tau Medical's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Tau Medical Enterprise Value Chart

Alpha Tau Medical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
- - - 120.42 141.20

Alpha Tau Medical Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 120.42 105.61 215.91 182.14 141.20

Competitive Comparison of Alpha Tau Medical's Enterprise Value

For the Biotechnology subindustry, Alpha Tau Medical's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpha Tau Medical's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Tau Medical's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Alpha Tau Medical's Enterprise Value falls into.



Alpha Tau Medical Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Alpha Tau Medical's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Alpha Tau Medical's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alpha Tau Medical  (NAS:DRTS) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Alpha Tau Medical's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=128.656/-29.066
=-4.43

Alpha Tau Medical's current Enterprise Value is $128.66 Mil.
Alpha Tau Medical's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-29.07 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Alpha Tau Medical's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=128.656/-29.066
=-4.43

Alpha Tau Medical's current Enterprise Value is $128.66 Mil.
Alpha Tau Medical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-29.07 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Alpha Tau Medical's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=128.656/0
=

Alpha Tau Medical's current Enterprise Value is $128.66 Mil.
Alpha Tau Medical's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alpha Tau Medical Enterprise Value Related Terms

Thank you for viewing the detailed overview of Alpha Tau Medical's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Alpha Tau Medical (Alpha Tau Medical) Business Description

Traded in Other Exchanges
N/A
Address
5 Kiryat Hamada Street, Building B3, 4th Floor, Jerusalem, ISR, 9777605
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors.